ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
Clinical trial NCT04326426 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04326426
- Sponsor
- Vanda Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-13
- Primary completion
- 2020-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.